WHR
57
2
DG
14
2
O
28
-7
ABBV
53
2
MAC
61
7
STT
56
5
TGT
52
2
CF
60
3
ETN
82
9
AES
49
-2
AA
45
2
TDC
49
2
KEY
54
6
MRK
50
-3
DIS
58
-2
XRAY
34
2
AVB
67
2
OI
50
7
FCX
58
5
MDLZ
67
-4
WHR
57
2
DG
14
2
O
28
-7
ABBV
53
2
MAC
61
7
STT
56
5
TGT
52
2
CF
60
3
ETN
82
9
AES
49
-2
AA
45
2
TDC
49
2
KEY
54
6
MRK
50
-3
DIS
58
-2
XRAY
34
2
AVB
67
2
OI
50
7
FCX
58
5
MDLZ
67
-4
Financhill
Back

Pacira BioSciences Quote, Financials, Valuation and Earnings

Free 23-page book shares my #1 indicator to use

Here's the 23-page free book.
Sell
33

PCRX
Pacira BioSciences

Last Price:
14.71
Seasonality Move:
-2.82%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Pacira BioSciences Price Quote

$14.71
+0.02 (+0.48%)
(Updated: September 20, 2024 at 5:38 AM ET)

Pacira BioSciences Key Stats

Sell
33
Pacira BioSciences (PCRX) is a Sell
Day range:
$14.50 - $15.23
52-week range:
$11.16 - $35.95
Dividend yield:
0%
P/E ratio:
16.51
P/S ratio:
1.19
P/B ratio:
0.77%
Volume:
895.1K
Avg. volume:
1.5M
1-year change:
-56.06%
Market cap:
$677.6M
Revenue:
$675M
EPS:
$1.33

How Much Does Pacira BioSciences Make?

Is Pacira BioSciences Growing As A Company?

  • What Is Pacira BioSciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.05%
  • What Is Pacira BioSciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.24%

Pacira BioSciences Stock Price Performance

What Is Pacira BioSciences 52-Week High & Low?

Pacira BioSciences Price To Free Cash Flow

Is It Risky To Buy Pacira BioSciences?

  • How Much Debt Does Pacira BioSciences Have?
    Total long term debt quarterly is $589.3M
  • How Much Cash Does Pacira BioSciences Have?
    Cash and short term investments quarterly total is $404.2M
  • What Is Pacira BioSciences’s Book Value Per Share?
    Book value per share is 19.07

Is Pacira BioSciences Cash Flow Positive?

  • What Is PCRX Cash Flow From Operations?
    Cash flow from operations (TTM) is $194.4M
  • What Is Pacira BioSciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$7.4M
  • What Is Pacira BioSciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$26.7M

Pacira BioSciences Return On Invested Capital

  • Is Management Doing A Good Job?
    PCRX return on invested capital is 4.55%
  • What Is Pacira BioSciences Return On Assets?
    ROA measures how assets are converting to revenues and is 4.03%
  • What Is PCRX Return On Equity?
    ROE is a measure of profitability and is 7.43%

Pacira BioSciences Earnings Date & Stock Price

Pacira BioSciences Competitors

Pacira BioSciences Dividend Yield

Pacira BioSciences Analyst Estimates

YoY Growth Past Surprise
EPS: -23.53% 27.3%
Revenue: 5.05% 2.5%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 4
Sell Recommendations: 1
Price Target: 18.00
Upside from Last Price: 22.53%

Major Shareholders

  • How many PCRX shares are owned by institutional investors?
    76.1M PCRX shares are owned by institutional investors
  • How many PCRX shares are owned by insiders?
    1.3M PCRX shares are owned by insiders